Infection Prevention Mandates — Infection control is a budget line hospitals defend first. The ECDC's 2022-2023 point prevalence survey found that 4.3 million patients in EU/EEA hospitals are affected by healthcare-associated infections each year, and the WHO's first global report on infection prevention and control in November 2024 concluded that good programmes can cut these infections by up to 70%. Single-use nonwoven barriers, from SMS gowns to sterilization wraps, are the physical layer of those programmes, which is why surgical & infection control already holds 44.0% of 2025 market value. Demand is shifting toward higher protection classes, not just more units. Ahlstrom's ChemoGard BVB, launched in July 2026, pairs AAMI Level 4 viral barrier performance with chemotherapy drug resistance and up to 240 minutes of protection against carmustine under ASTM D6978. That's a premium product for a premium use case: oncology pharmacies and infusion suites.
Medical Nonwoven Products Market Size, Share & Growth 2026–2035
Medical Nonwoven Products Market by Product Type (Surgical Gowns & Drapes, Wound Care Dressings, Face Masks & Respirators, Sterilization Wraps, Drapes for ophthalmic and dental use and filtration media), by Material (Polypropylene-Based, Polyester-Based, Rayon, Rayon/viscose and bicomponent materials), by Application (Surgical & Infection Control, Wound Care, Incontinence Products, Hygiene and personal care), by End User (Hospitals, Ambulatory Surgical Centers, Homecare Settings), and by Region — Global Industry Perspective, Comprehensive Analysis, and Forecast 2026–2035
Medical Nonwoven Products Industry Perspective
The Global Medical Nonwoven Products market was valued at USD 1,372.4 Mn in 2025 and is projected to reach USD 3,772.3 Mn by 2035, growing at a CAGR of 10.64% during the forecast period 2026–2035, according to Vectomat Insights.
The structural story sits in the operating room: surgical & infection control applications already account for 44.0% of 2025 value and keep gaining share through 2035, as procedures migrate to ambulatory surgical centers that buy single-use barrier products in standardised procedure packs.
Medical Nonwoven Products Market: Overview
Medical Nonwoven Products Market encompasses finished medical goods built on spunbond, meltblown, SMS, spunlace and needlepunch fabrics, covering five product types (surgical gowns & drapes, wound care dressings, face masks & respirators, sterilization wraps, and ophthalmic, dental and filtration drapes) made from polypropylene, polyester and rayon/viscose or bicomponent fibres. The report scope follows these products from roll goods to the point of use in hospitals, ambulatory surgical centers and homecare settings, across surgical, wound care, incontinence and hygiene applications.
The value chain runs in three tiers. Foundational roll-goods producers, among them Freudenberg Performance Materials, Magnera, Ahlstrom, Suominen and Nonwovenn, turn polymer and fibre into barrier and absorbent fabrics. Specialist developers such as Mölnlycke Health Care, Paul Hartmann AG, Lohmann & Rauscher, Solventum, Winner Medical and Ansell engineer those fabrics into regulated dressings, drapes and protective products. Application-layer specialists, including Halyard, Medline Industries and Cardinal Health, convert, kit and distribute gowns, drapes and procedure packs into hospital supply contracts.
For procurement directors and investors, the volume-value split matters more than the headline CAGR: masks ship the most units, yet gowns, drapes and wound dressings carry the margin. This report sizes four segmentation dimensions across 35+ countries, so buyers can see which products, materials and care settings will capture disproportionate share of the USD 2.4 Bn added between 2025 and 2035.
According to European Centre for Disease Prevention and Control (ECDC), point prevalence survey 2022-2023, 2024-05, Each year, 4.3 million patients in hospitals in the EU/EEA are affected by healthcare-associated infections, which keeps single-use nonwoven barrier products at the centre of hospital infection-prevention spending.

Key Insights
- The market is projected to grow from USD 1,372.4 Mn in 2025 to USD 3,772.3 Mn by 2035 at a 10.64% CAGR, according to Vectomat Insights.
- Surgical gowns & drapes are the dominant product type at 32.0% of 2025 revenue (USD 439.2 Mn).
- Face masks & respirators are the fastest-growing product type at a 14.99% CAGR, rising to USD 1,109.4 Mn by 2035 and overtaking gowns & drapes as the largest category.
- Polypropylene-based materials account for 53.7% of 2025 value; rayon/viscose and bicomponent materials grow fastest at a 15.1% CAGR.
- Surgical & infection control is the dominant application at 44.0% of 2025 value, while hygiene and personal care grows fastest at 15.08%.
- Hospitals buy 51.4% of 2025 volume by value; ambulatory surgical centers are the fastest-growing end user at a 15.03% CAGR.
- North America leads with a 31.0% share (USD 425.4 Mn); Asia Pacific is the fastest-growing region, with South Korea compounding at 12.8%.
- Ownership is consolidating: Halyard, Nonwovenn and Foshan United Medical all changed hands between December 2025 and July 2026.
- US tariffs on Chinese nonwoven fabric rose to 20% in March 2025, pushing buyers toward Vietnam, Thailand and domestic supply through the 2026–2035 forecast period.

Medical Nonwoven Products Market: Report Scope
| Report Name | Medical Nonwoven Products Market by Product Type (Surgical Gowns & Drapes, Wound Care Dressings, Face Masks & Respirators, Sterilization Wraps, Drapes for ophthalmic and dental use and filtration media), by Material (Polypropylene-Based, Polyester-Based, Rayon, Rayon/viscose and bicomponent materials), by Application (Surgical & Infection Control, Wound Care, Incontinence Products, Hygiene and personal care), by End User (Hospitals, Ambulatory Surgical Centers, Homecare Settings), and by Region — Global Industry Perspective, Comprehensive Analysis, and Forecast 2026–2035 |
|---|---|
| Market Size in 2025 | USD 1,372.4 Mn (2025) |
| Market Forecast in 2035 | USD 3,772.3 Mn (2035) |
| Growth Rate (CAGR) | 10.64% |
| Historical Data Period | 2023–2025 |
| Base Year | 2025 |
| Forecast Period | 2026–2035 |
| Number of Pages | 300+ |
| Tables & Figures | 92 tables & 66 figures |
| Report Code | VMI-1-7-46896 |
| Report Format | |
| Delivery Format | Electronic (PDF), Excel add-on available on request |
| Published Date | November 2026 |
| Research Methodology | Primary interviews + secondary research + verified market sizing (top-down and bottom-up triangulation) |
| Key Companies Covered | Freudenberg Performance Materials, Magnera, Ahlstrom, Suominen, Nonwovenn, Mölnlycke Health Care, Paul Hartmann AG, Lohmann & Rauscher, Solventum, Winner Medical, Ansell, Halyard, Medline Industries, Cardinal Health |
| Segments Covered | Product Type, Material, Application, End User |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, The Middle East, Africa |
| Customization Scope | Up to 10% free customization on top of the standard report scope. Available on request — additional segments, geographies, or extended forecast periods |
What Sets This Medical Nonwoven Products Market Report Apart?
Decision-makers comparing market intelligence reports on Medical Nonwoven Products will find the VMI report differentiated on the following dimensions.
| Dimension | VMI Report | Industry Average |
|---|---|---|
| Report Pages | 300+ | ~120 pages |
| Forecast Horizon | 10 years | 7 years |
| Segmentation Dims | 4 dims | 4-5 dimensions |
| Historical Data | 3 years | 4-5 years |
| Country Coverage | 35+ countries | 15-18 countries |
| Companies Profiled | 14 companies | 10-12 companies |
| DROC Framework | Full (4 elem) | Drivers only |
For custom scope — additional segments, specific geographies, or extended forecast periods — contact sales@vectomatinsights.com
Medical Nonwoven Products Market Growth Drivers
Outpatient Surgery Shift to ASCs — Surgery is moving out of the hospital, and the barrier products are moving with it. CMS's CY2026 OPPS/ASC final rule, released in November 2025, expands the ASC covered procedures list, adding cases that can be performed in freestanding centers rather than hospital operating rooms. Ambulatory surgical centers are consequently the fastest-growing end user in this report, compounding at 15.03% from USD 305.7 Mn in 2025 to USD 1,240.0 Mn by 2035. ASCs buy differently from hospitals: they favour standardised custom procedure packs that bundle gowns, drapes and wraps for a single case, which raises the value captured per procedure. Mölnlycke Health Care made its largest-ever manufacturing investment, about EUR 115 million in Wiscasset, Maine, in July 2025, adding capacity close to the US outpatient market. Structurally, this driver converts procedure growth into nonwoven revenue at a higher price point per case than hospital tray assembly.
Supply Security and Nearshoring — The pandemic taught health systems that a single sourcing country is a single point of failure, and tariffs have turned that lesson into a pricing problem. US duties on Chinese nonwoven fabric rose to 10% on 4 February 2025 and 20% on 4 March 2025, while USTR's Section 301 actions raised tariffs on Chinese facemasks and respirators in phases through 2026. Manufacturers are responding with new capacity in tariff-advantaged locations. Winner Medical broke ground on a USD 60 Mn, 93,000-square-metre production base in Quang Ninh, Vietnam, in May 2026, with mass production of advanced dressings and operating room consumables planned from the third quarter of 2027. Governments are paying for domestic capacity too: HHS/ASPR's Industrial Base Expansion programme funded US N95 respirator lines, and CMS asked for input on domestic PPE supply chains in January 2026. Expect dual-sourcing clauses to become standard in GPO contracts for gowns, drapes and masks by the end of the decade.
Freudenberg Performance Materials and Foshan United Medical are a perfect strategic match. Going forward, the merger will enable us to offer a unique portfolio of technologies and products as an innovative full-service supplier in the market for advanced wound care.
Medical Nonwoven Products Market Challenges to Growth
Tariff and Trade Policy Exposure — Trade policy has become a cost line no buyer can forecast. China remains the largest single source of US nonwoven fabric imports by volume, so the February and March 2025 tariff increases landed directly on converters and distributors of gowns, drapes and masks. The American Hospital Association asked the Administration in February 2025 to exempt medical supplies, warning that tariffs could reduce the availability of everyday medical supplies. Then the Supreme Court's February 2026 ruling against tariffs imposed under IEEPA reopened the question of which duties stand, while Section 301 tariffs on PPE stayed in place. Cardinal Health disclosed tariff costs and workforce reductions in its medical segment alongside its fiscal third-quarter 2025 results in May 2025.
Margin Pressure and Single-Use Scrutiny — Volume growth isn't translating into producer margin. Suominen reported 2025 net sales down 10.8% to EUR 412.4 million and described a market shaped by excess capacity and shifting trade flows, while Magnera exited Argentina as part of its Project CORE restructuring. Polypropylene oversupply, which pushed European prices toward a five-year low in September 2025, lowers input costs but also erodes the price floor for commodity spunbond. Sustainability adds a second squeeze: a University of Sussex study found single-use items account for about two-thirds of the carbon footprint of products used in common NHS operations, strengthening the case for reusable gowns in Europe. This restraint is structural rather than cyclical, because it favours suppliers with differentiated barrier fabrics over commodity roll-goods producers.
Tariffs, as well as any reaction of the countries on whom such tariffs are imposed, could reduce the availability of these life-saving medications and supplies in the U.S.
The nonwovens market kept growing in 2025, but excess capacity and shifting trade flows shaped its dynamics, and our own results and delivery reliability fell short of expectations.
Medical Nonwoven Products Market Growth Opportunities
Integrated Advanced Wound Care — Fabric makers are buying their way into finished dressings. Freudenberg Performance Materials acquired Foshan United Medical Technologies in July 2026, gaining a Chinese supplier integrated across fibre manufacturing, nonwoven production, sterilization and marketing authorization for silver-containing and alginate dressings. Wound care dressings already hold 24.0% of 2025 product revenue and grow at 10.2% to USD 870.1 Mn by 2035, while rayon/viscose and bicomponent materials, the fibres behind absorbent dressings, compound fastest at 15.1%. Suppliers that control the full chain can price on clinical outcome rather than fabric weight. Asia Pacific and Europe offer the clearest runway for this model.
PFAS-Free and Lower-Carbon Materials — Chemistry rules are creating a product refresh cycle. Ahlstrom built ChemoGard BVB on a PFAS-free construction, and Nonwovenn expanded a PFAS-free ostomy care range in February 2026, as European restrictions on fluorinated chemistry tighten. Hospitals with net-zero targets are writing material and carbon criteria into gown and drape tenders, which rewards suppliers who can document lower-footprint fabrics. The opportunity sits mainly with Europe-based roll-goods makers that already run medical-grade lines. Structurally, this shifts competition from price per square metre to compliance and documentation.
Local Production in Emerging Markets — Local content policies are pulling capacity toward new demand centres. Saudi German Nonwovens invested in a new Reicofil R5 spunmelt line, SABIC's polymers enabled the first local N95 mask production in Saudi Arabia, and Lohmann & Rauscher has invested in a production site in Ethiopia. India supports the same shift through its National Technical Textiles Mission and a textiles PLI scheme whose investment thresholds were halved in October 2025. Suppliers that license technology or co-invest early will hold the tender positions as hospital construction in the GCC and India accelerates through 2030.
Medical Nonwoven Products Market: Key Challenges
Ownership Churn and Contract Continuity — Consolidation brings integration risk to buyers. Platinum Equity took over Halyard in December 2025, CorpAcq acquired Nonwovenn in January 2026 and Freudenberg bought Foshan United Medical in July 2026. Each change can trigger product rationalisation, new pricing and regulatory file transfers that hospitals must requalify. Procurement teams that sole-source gowns or wraps carry the most exposure.
Regulatory Recertification Burden — Every barrier claim needs a current file. Regulation (EU) 2023/607 pushed MDR transition deadlines to 2027-2028, but legacy gowns, drapes and masks still need notified-body recertification against European performance standards. In the US, gowns and drapes require FDA 510(k) clearance or exemption, with barrier levels tested against AAMI PB70. For smaller converters, the documentation cost per product line is a real barrier to entry rather than a formality.
The nonwovens industry supports fair trade and a level playing field.

AI's Impact on the Medical Nonwoven Products Market
Machine vision is the most concrete AI application in this market, and it sits on the production line rather than in the hospital. ISRA VISION's NOWO inspect system scans nonwoven webs at line speed for holes, thin spots and contamination, the defects that would compromise a gown's or wrap's barrier rating, while ANDRITZ's Metris platform collects process data from spunlace and spunbond lines to predict quality drift. For medical fabrics, where a single pinhole can fail an AAMI PB70 test, automated inspection cuts scrap and gives auditors a defect record for every roll.
For buyers, this means barrier claims backed by roll-level inspection data rather than batch sampling, which matters as hospitals tighten supplier qualification after tariff-driven sourcing changes. Over the forecast horizon, expect AI-assisted inspection data to move from a plant-floor tool into supplier scorecards that GPOs use when awarding gown and drape contracts.
Medical Nonwoven Products Market: Segmentation
The Global Medical Nonwoven Products market is segmented by Product Type, Material, Application, End User.
By Product Type
Ahlstrom's July 2026 launch of ChemoGard BVB, an AAMI Level 4 breathable gown fabric rated for chemotherapy handling, shows where product value is heading: higher barrier classes, sold at higher prices. Surgical gowns & drapes remain the dominant product type at 32.0% of 2025 revenue, worth USD 439.2 Mn, because every procedure consumes a gown set and a drape pack. Face masks & respirators are the fastest-growing type at a 14.99% CAGR, climbing from USD 274.5 Mn to USD 1,109.4 Mn by 2035 as stockpile replenishment, domestic N95 programmes and routine masking in outpatient care lift volumes. Sterilization wraps add a 12.6% CAGR on rising instrument reprocessing. Ophthalmic, dental and filtration drapes trail at 5.41%.
Product Type-Wise Revenue Breakdown for the Medical Nonwoven Products Market, 2023–2025 (USD Million)
| Sub-Segment | 2023 (USD Mn) | 2024 (USD Mn) | 2025 (USD Mn) |
|---|---|---|---|
| Surgical Gowns & Drapes | 360.3 | 387.5 | 439.2 |
| Wound Care Dressings | 270.6 | 301.4 | 329.4 |
| Face Masks & Respirators | 237.0 | 269.1 | 274.5 |
| Sterilization Wraps | 131.3 | 153.6 | 192.1 |
| Drapes for ophthalmic and dental use and filtration media | 144.1 | 147.8 | 137.2 |

By Material
Magnera, formed in November 2024 from Berry Global's spunmelt business and Glatfelter, is the clearest bet on polypropylene's staying power in medical fabrics. Polypropylene-based materials hold 53.7% of 2025 value, or USD 736.9 Mn, since spunbond and SMS polypropylene combines fluid barrier, low cost and sterilization compatibility for gowns, drapes, masks and wraps. Rayon, rayon/viscose and bicomponent materials are the fastest-growing group at a 15.1% CAGR, reaching USD 1,231.7 Mn by 2035, because spunlace and bicomponent fabrics carry the softness and absorbency wound dressings need. Polyester-based materials grow slowest at 5.39%, losing share to both.
Material-Wise Revenue Breakdown for the Medical Nonwoven Products Market, 2023–2025 (USD Million)
| Sub-Segment | 2023 (USD Mn) | 2024 (USD Mn) | 2025 (USD Mn) |
|---|---|---|---|
| Polypropylene-Based | 617.9 | 676.8 | 736.9 |
| Polyester-Based | 300.7 | 318.0 | 333.6 |
| Rayon, Rayon/viscose and bicomponent materials | 224.7 | 264.6 | 301.9 |
By Application
Lohmann & Rauscher's April 2025 purchase of UK procedure-pack maker Unisurge reflects where buyers want to spend: on complete surgical kits rather than loose items. Surgical & infection control is the dominant application at 44.0% of 2025 value, or USD 603.9 Mn, and it keeps gaining share to 49.2% by 2035 because gowns, drapes, masks and wraps are funded inside the infection-prevention bundle. Hygiene and personal care is the fastest-growing application at a 15.08% CAGR, from USD 164.7 Mn to USD 671.1 Mn. Wound care grows at 8.7%, while incontinence products slow to 5.51% as price competition with consumer brands caps value.
Application-Wise Revenue Breakdown for the Medical Nonwoven Products Market, 2023–2025 (USD Million)
| Sub-Segment | 2023 (USD Mn) | 2024 (USD Mn) | 2025 (USD Mn) |
|---|---|---|---|
| Surgical & Infection Control | 463.4 | 558.0 | 603.9 |
| Wound Care | 306.4 | 317.1 | 356.8 |
| Incontinence Products | 261.9 | 246.3 | 247.0 |
| Hygiene and personal care | 111.6 | 138.0 | 164.7 |
By End User
Medline's December 2025 Nasdaq listing, one of the year's largest IPOs, underlines how much of this market still flows through hospital supply contracts. Hospitals are the dominant end user at 51.4% of 2025 value, or USD 705.3 Mn, buying gowns, drapes, wraps and dressings through GPO agreements. Ambulatory surgical centers are the fastest-growing end user at a 15.03% CAGR, expanding from USD 305.7 Mn to USD 1,240.0 Mn by 2035, as CMS's CY2026 payment rule adds procedures that can move out of the hospital. Homecare settings, at USD 361.4 Mn, grow at 5.46% as incontinence and basic dressings face price pressure.
End User-Wise Revenue Breakdown for the Medical Nonwoven Products Market, 2023–2025 (USD Million)
| Sub-Segment | 2023 (USD Mn) | 2024 (USD Mn) | 2025 (USD Mn) |
|---|---|---|---|
| Hospitals | 692.2 | 672.2 | 705.3 |
| Ambulatory Surgical Centers | 192.7 | 229.5 | 305.7 |
| Homecare Settings | 258.4 | 357.7 | 361.4 |


Medical Nonwoven Products Market: Production & Volume Analysis, 2025
Vectomat Insights estimates that about 2,690 million medical nonwoven pieces were produced for this market in 2025. Face masks & respirators lead on volume with 56.7% of units, yet they earn only 20.0% of revenue at roughly USD 0.18 per piece. Surgical gowns & drapes show the opposite profile: 6.8% of units but 32.0% of value, at about USD 2.40 per piece. Wound care dressings carry 22.2% of units. Across all five product types, the implied average selling price is about USD 0.51 per piece, a volume-value split that keeps gowns and drapes at the centre of supplier margins.
| Metric | 2025 Volume (million pieces produced) | Share of Units |
|---|---|---|
| Total million pieces produced (2025) | 2,690 | 100.0% |
| Surgical Gowns & Drapes | 183 | 6.8% |
| Wound Care Dressings | 597 | 22.2% |
| Face Masks & Respirators | 1,525 | 56.7% |
| Sterilization Wraps | 213 | 7.9% |
| Drapes for ophthalmic and dental use and filtration media | 172 | 6.4% |
Reference point: Owens & Minor (Halyard) — Added domestic N95 respirator capacity under HHS/ASPR's Industrial Base Expansion programme for the US Strategic National Stockpile (2021–2025).
Medical Nonwoven Products Market: Competitive Landscape
Concentration in this market sits at the two ends of the chain, not the middle. A handful of roll-goods producers supply the barrier fabrics, and a few vertically integrated distributors control hospital contracts, while dozens of regional converters fill the space between. Mergers are compressing that middle tier fast: Platinum Equity's Halyard deal, CorpAcq's Nonwovenn purchase and Freudenberg's acquisition of Foshan United Medical all closed within eight months. Tier one competes on fabric science and capacity, tier two on regulated product engineering, and tier three on contract breadth and procedure-pack kitting. Key players include Freudenberg Performance Materials, Magnera, Ahlstrom, Suominen, Nonwovenn, Mölnlycke Health Care, Paul Hartmann AG, Lohmann & Rauscher, Solventum, Winner Medical, Ansell, Halyard, Medline Industries, Cardinal Health, among others.
| Company | HQ Country | Primary Focus | Key Strategy | Notable Recent Action |
|---|---|---|---|---|
| Freudenberg Performance Materials | Germany | Spunbond, needlepunch and spunlace medical fabrics and wound care materials | Moving up the value chain into finished advanced wound care through acquisitions in Asia | Acquired China-based advanced wound care maker Foshan United Medical Technologies in July 2026 |
| Magnera | United States | Spunmelt and specialty nonwovens for healthcare, hygiene and wipes | Scale and cost synergies from the Berry HHNF–Glatfelter combination, plus portfolio pruning under Project CORE | Announced a strategic exit from Argentina under its Project CORE transformation in 2025, after completing the Berry HHNF–Glatfelter merger in November 2024 |
| Ahlstrom | Finland | Medical barrier fabrics, sterilization wraps and filtration media | Premium barrier-performance innovation for gowns and sterile packaging | Launched ChemoGard BVB, a breathable AAMI Level 4 fabric for chemotherapy handling, in July 2026 |
| Suominen | Finland | Nonwoven roll goods for wipes, including healthcare and medical wipes | Cost-saving and efficiency programme targeting a 10% adjusted EBITDA margin by 2028 | Published 2025 results in January 2026 under new President & CEO Charles Héaulmé, with a cost-saving programme to restore profitability |
| Nonwovenn | United Kingdom | Hydroentangled (spunlace) nonwovens for wound care, ostomy and protective clothing | Medical-grade capacity build-out and platform role for further technical textile acquisitions | Acquired by CorpAcq in January 2026, after investing in a Class 8 cleanroom MediTech suite in June 2025 |
| Mölnlycke Health Care | Sweden | Advanced wound care and single-use surgical products | Global manufacturing footprint expansion, including localisation in China and the US | Opened its first wound care manufacturing site in Changshu, China, in November 2025 |
| Paul Hartmann AG | Germany | Wound care, incontinence management, infection management and OR procedure packs | Transformation programme focused on margin recovery and core medical categories | Reported 2025 group revenue of EUR 2.45 billion with higher EBITDA from its transformation programme in its 2026 annual results |
| Lohmann & Rauscher | Germany | Wound care, compression and custom surgical procedure packs | M&A-led nearshoring of procedure-pack and wound care capacity in Europe | Acquired UK custom procedure pack maker Unisurge International in April 2025 |
| Solventum | United States | Infection prevention, sterilization assurance and advanced wound care | Portfolio focus on MedSurg after the 3M spin-off | Completed the USD 4.1 billion sale of its Purification & Filtration business to Thermo Fisher Scientific in September 2025 |
| Winner Medical | China | Medical dressings, surgical consumables and cotton spunlace nonwovens | Overseas manufacturing to serve global customers from tariff-advantaged locations | Broke ground on a USD 60 Mn production base in Quang Ninh, Vietnam, in May 2026 |
| Ansell | Australia | Surgical and examination gloves, protective apparel and PPE | Scale in healthcare PPE through the acquired Kimberly-Clark PPE business | Reported FY2025 results in August 2025, the first full year including the acquired Kimberly-Clark PPE business |
| Halyard | United States | Surgical gowns, drapes, sterilization wraps and N95 respirators | Standalone growth under private ownership with integrated manufacturing and distribution | Acquired by Platinum Equity when Owens & Minor completed the sale of its Products & Healthcare Services business in December 2025 |
| Medline Industries | United States | Med-surg manufacturing and distribution, including gowns, drapes and procedure packs | Vertical integration across manufacturing, kitting and hospital distribution | Completed its Nasdaq IPO in December 2025, one of the largest listings of the year |
| Cardinal Health | United States | Cardinal Health-brand med-surg products, including gowns, drapes and procedure packs | Cost restructuring and supply diversification to absorb tariff costs | Raised its fiscal 2025 earnings outlook in May 2025 while disclosing tariff costs and workforce reductions in its medical segment |
Three strategic themes stand out. First, vertical integration: Freudenberg and Lohmann & Rauscher are buying finished-product makers to capture dressing and procedure-pack margins. Second, geographic hedging, with Winner Medical in Vietnam and Mölnlycke in China and Maine building capacity closer to demand and away from tariff exposure. Third, portfolio focus, as Solventum and Owens & Minor shed non-core units. Share gains to 2035 will go to suppliers that control fabric and finished product together.

Medical Nonwoven Products Market: Value Chain Overview
Polymer, fibre and roll-goods production — Polypropylene, polyester and viscose resins and fibres are converted into spunbond, meltblown, SMS and spunlace fabrics on capital-intensive lines from builders such as Reicofil and ANDRITZ. This stage sets barrier class, basis weight and absorbency, and it carries the polymer cost exposure. Producers including Freudenberg Performance Materials, Magnera, Ahlstrom, Suominen and Nonwovenn sell roll goods under multi-year supply agreements to converters and medical brands. Key Players: Magnera.
Conversion, sterilization and product engineering — Specialist manufacturers cut, laminate, sew or ultrasonically weld fabrics into gowns, drapes, masks, wraps and dressings, then sterilize them by ethylene oxide or gamma irradiation. Regulatory files under FDA 510(k), EU MDR and NMPA sit here, as does most product differentiation. Mölnlycke Health Care, Paul Hartmann AG, Lohmann & Rauscher, Winner Medical and Solventum own the clinical claims and much of the margin at this stage. Key Players: Mölnlycke Health Care.
Kitting, distribution and hospital procurement — Finished products reach hospitals, ambulatory surgical centers and homecare providers through vertically integrated distributors and GPO contracts, often bundled into custom procedure packs assembled for a specific surgery. Medline Industries, Cardinal Health and Halyard compete on contract coverage, fill rates and the ability to switch fabric origin when tariffs move. Purchasing decisions at this stage set price benchmarks for the whole chain. Key Players: Medline Industries.
Medical Nonwoven Products Market: Regional Analysis
North America leads the Global Medical Nonwoven Products market with 31.0% of 2025 revenue, while Asia Pacific, at 30.0%, is growing fastest. The split is structural: North America's lead rests on high per-procedure spending on barrier products, while Asia Pacific is adding hospital capacity and new production lines at the same time.
North America Medical Nonwoven Products Market
Platinum Equity's December 2025 purchase of Owens & Minor's Products & Healthcare Services business put the Halyard gown, drape and wrap franchise under new ownership, and it happened in the largest regional market. North America holds 31.0% of 2025 revenue, worth USD 425.4 Mn. The United States accounts for USD 319.0 Mn of that and compounds at 9.4% to USD 783.4 Mn by 2035, supported by dense hospital surgical volumes, AAMI PB70 barrier classifications and federal domestic-sourcing programmes for N95 respirators. CMS's January 2026 request for input on domestic PPE supply chains signals more policy attention ahead. The principal challenge is tariff volatility: duties on Chinese nonwoven fabric reached 20% in March 2025, and the Supreme Court's February 2026 ruling on IEEPA tariffs reopened pricing questions. Medline, Cardinal Health and Halyard anchor domestic distribution.
United States Medical Nonwoven Products Market Snapshot
| Metric | Value |
|---|---|
| Market Size (2025) | USD 319.0 Mn |
| Forecast Value (2035) | USD 783.4 Mn |
| CAGR (2026–2035) | 9.4% |

Europe Medical Nonwoven Products Market
Freudenberg Performance Materials, headquartered in Weinheim, bought Chinese wound care maker Foshan United Medical in July 2026, proof that Europe's suppliers are buying growth outside the region. Europe holds 25.58% of 2025 revenue, or USD 351.02 Mn. Germany is the largest country market at USD 99.9 Mn, growing at 9.0% to USD 236.5 Mn by 2035, with Paul Hartmann and Lohmann & Rauscher supplying wound care and procedure packs across its hospital network. The ECDC estimates 4.3 million EU/EEA hospital patients are affected by healthcare-associated infections each year, which keeps infection-control budgets protected. The main challenge is regulatory cost: MDR certification deadlines run to 2027-2028, and NHS-led carbon studies favour reusables. Europe is a mature, standards-led market where share gains come from product upgrades, not new beds.
Germany Medical Nonwoven Products Market Snapshot
| Metric | Value |
|---|---|
| Market Size (2025) | USD 99.9 Mn |
| Forecast Value (2035) | USD 236.5 Mn |
| CAGR (2026–2035) | 9% |

Asia Pacific Medical Nonwoven Products Market
Mölnlycke Health Care opened its first wound care manufacturing site in Changshu, China, in November 2025, and Winner Medical broke ground on a USD 60 Mn base in Vietnam in May 2026. Asia Pacific holds 30.0% of 2025 revenue, or USD 411.7 Mn, and it is the fastest-growing region. South Korea is worth USD 82.3 Mn and compounds at 12.8%, reaching USD 274.5 Mn by 2035, the highest growth rate among the highlighted countries. Japan is larger at USD 119.4 Mn and grows at 10.9% on ageing-driven wound care and incontinence demand. China remains the region's production base. The challenge is margin: Chinese export pricing and US tariffs on Chinese fabric push suppliers toward Vietnam, Thailand and India. Expect Asia Pacific to overtake North America on revenue within the forecast horizon.
South Korea Medical Nonwoven Products Market Snapshot
| Metric | Value |
|---|---|
| Market Size (2025) | USD 82.3 Mn |
| Forecast Value (2035) | USD 274.5 Mn |
| CAGR (2026–2035) | 12.8% |

Latin America Medical Nonwoven Products Market
Fitesa, headquartered in Brazil, operates spunmelt lines across the Americas and gives the region a home-grown supplier of medical and hygiene fabrics. Latin America holds 6.0% of 2025 revenue, worth USD 82.3 Mn. Brazil is the largest national market, regulated by ANVISA and supplied by a mix of domestic production and imports, while Argentina has seen multinational exits such as Magnera's 2025 withdrawal under its Project CORE programme. Private hospital groups are upgrading to higher barrier-class gowns and drapes, but currency volatility and anti-dumping investigations on imported nonwovens complicate procurement. Latin America's 6.0% share is likely to edge up only slowly over the forecast period.
The Middle East Medical Nonwoven Products Market
Saudi German Nonwovens has invested in a new Reicofil R5 spunmelt line, and SABIC's polymers enabled the first local production of N95 masks in Saudi Arabia. The Middle East holds 4.0% of 2025 revenue, or USD 54.9 Mn. GCC hospital construction and local-content rules in Saudi Arabia and the UAE are creating demand for surgical gowns, drapes and masks close to the point of use, while Israel and Turkey add converting capacity. Regulatory frameworks are still developing across the region. The limiting factor is scale: local converters remain few, so most finished products are still imported. SABIC's polymer supply is the region's clearest route to a vertically integrated chain.
Africa Medical Nonwoven Products Market
Lohmann & Rauscher's investment in an Ethiopian production site shows that multinational suppliers are starting to build capacity on the continent rather than only shipping to it. Africa holds 3.42% of 2025 revenue, worth USD 46.98 Mn, led by South Africa and Egypt, where public hospital tenders set most purchasing. Demand centres on basic masks, gowns and wound dressings for infection prevention, with donor-funded programmes supporting supply in lower-income markets. The principal constraint is procurement design: price-led tenders rarely reward higher barrier classes. Africa's position in this market is defined less by current spend than by whether local converting capacity takes hold.


Full Country Coverage
| Region | Countries Covered |
|---|---|
| North America | The U.S., Canada, Mexico |
| Europe | Germany, France, U.K., Italy, Spain, Russia, BENELUX, Sweden, Denmark, Poland, Austria, Rest of Europe |
| Asia Pacific | China, Japan, India, South Korea, Australia, Thailand, Indonesia, Vietnam, Malaysia, Philippines, Taiwan, Rest of Asia Pacific |
| Latin America | Brazil, Argentina, Colombia, Chile, Peru, Rest of Latin America |
| The Middle East | GCC (Saudi Arabia, UAE, Qatar, Kuwait, Bahrain, Oman), Israel, Turkey, Iran, Rest of Middle East |
| Africa | South Africa, Egypt, Nigeria, Algeria, Morocco, Rest of Africa |
Note: Country-level market sizing, historical data, and forecasts available for all geographies listed. Custom regional add-ons available — contact sales@vectomatinsights.com
Policy and Government Support Shaping the Medical Nonwoven Products Market
Domestic PPE manufacturing programme — The US Department of Health and Human Services, through ASPR's Industrial Base Expansion portfolio, has funded domestic N95 respirator capacity at manufacturers including Owens & Minor's Halyard unit, and CMS opened a request for input on domestic PPE supply chains in January 2026. (HHS/ASPR Industrial Base Expansion (IBx))
Regulatory-approval programme — Regulation (EU) 2023/607 extended the EU Medical Device Regulation transition to 2027-2028 depending on risk class, giving nonwoven gown, drape and mask makers more time to recertify legacy products under MDR. (EU Medical Device Regulation (EU) 2017/745, transition extended by Regulation (EU) 2023/607)
Industrial development and funding initiative — India's National Technical Textiles Mission, which completed five years in March 2025, and the textiles PLI scheme for man-made fibre and technical textiles, whose investment thresholds were halved in October 2025, support domestic medical textile production. (National Technical Textiles Mission (India))
Trade and tariff policy — USTR's Section 301 review raised tariffs on Chinese facemasks, respirators and medical gloves in phases from 2024 to 2026, separate from the 2025 tariff increases on Chinese nonwoven fabric, steering US buyers toward domestic and non-Chinese supply. (USTR Section 301 tariff actions)
Recent Developments in the Medical Nonwoven Products Market
Recent activity in medical nonwovens is dominated by ownership changes and new capacity in Asia, as suppliers integrate fabric and finished product while hedging against tariffs.
| Date | Company | Type | Description | Market Impact |
|---|---|---|---|---|
| Apr 2025 | Lohmann & Rauscher | M&A | Lohmann & Rauscher acquired Unisurge International, a UK maker of custom surgical procedure packs. [source] | Adds UK kitting capacity and supports L&R's nearshoring of procedure-pack supply in Europe. |
| Dec 2025 | Platinum Equity, Owens & Minor | M&A | Owens & Minor completed the sale of its Products & Healthcare Services business, including the Halyard gown, drape and wrap franchise, to Platinum Equity. [source] | Puts one of the largest US surgical barrier portfolios under private ownership as a standalone company. |
| Jan 2026 | CorpAcq, Nonwovenn | M&A | CorpAcq acquired UK spunlace producer Nonwovenn, which supplies wound care, ostomy and protective clothing fabrics. [source] | Creates a platform for further technical textile acquisitions in UK medical nonwovens. |
| May 2026 | Winner Medical | Investment | Winner Medical broke ground on a USD 60 Mn production base in Quang Ninh, Vietnam, for advanced dressings and operating room consumables. [source] | Adds tariff-advantaged capacity for US and European customers, with mass production planned from Q3 2027. |
| Jul 2026 | Freudenberg Performance Materials | M&A | Freudenberg acquired Foshan United Medical Technologies, a Chinese advanced wound care maker integrated from fibre to sterilisation. [source] | Moves a leading roll-goods producer into finished silver and alginate dressings in China. |
| Jul 2026 | Ahlstrom | Product Launch | Ahlstrom launched ChemoGard BVB, a breathable PFAS-free fabric with AAMI Level 4 viral barrier and chemotherapy drug resistance. [source] | Raises the barrier and comfort benchmark for gowns used in oncology and pharmacy settings. |
Research Methodology
Overall approach
Vectomat Insights sized the Medical Nonwoven Products market from both directions. The bottom-up model builds product-type revenue from procedure volumes, per-procedure consumption of gowns, drapes, wraps and masks, wound care patient pools and average selling prices by region; the top-down model starts from reported medical revenues of the leading roll-goods producers, converters and distributors and allocates them by product, material, application and end user. The two estimates were reconciled to a single base-year value of USD 1,372.4 Mn for 2025.
Primary research
Primary research covered interviews with procurement and supply chain managers at hospitals and ambulatory surgical centers, product managers at nonwoven roll-goods producers and converters, and distributors handling gowns, drapes and procedure packs in North America, Europe and Asia Pacific. Interviews focused on price per piece by barrier class, procedure-pack composition, fabric sourcing after the 2025 tariff changes and the outlook for reusable alternatives.
Secondary research
Secondary research drew on company annual reports, investor presentations and press releases from suppliers such as Freudenberg Performance Materials, Magnera, Ahlstrom, Mölnlycke Health Care and Suominen; regulator and agency publications from the FDA, ECDC, WHO, CMS, HHS/ASPR and USTR; trade association material from INDA and EDANA; and trade press including Nonwovens Industry and Textile World.
Data validation
Segment and sub-segment values were reconciled to the base-year total for every year from 2023 to 2025, and regional values were checked to sum to the global market. Country values for the United States, Germany, Japan and South Korea were checked against their regional totals. Product-type revenues were cross-checked against reported medical revenues of leading companies and against implied per-piece prices for gowns, drapes, masks, wraps and dressings.
Market Coverage Definitions
How this report defines the scope of the Medical Nonwoven Products Market: what each segment and sub-segment includes.
| Segment | Market Coverage Definition |
|---|---|
| By Product Type | Segments the market by finished product, covering surgical gowns and drapes, wound care dressings, face masks and respirators, sterilization wraps, and other products. |
| By Material | Segments the market by the fiber basis of the nonwoven fabric, covering polypropylene-based, polyester-based, and rayon and other materials. |
| By Application | Segments the market by clinical use, covering surgical and infection control, wound care, incontinence products, and other applications. |
| By End User | Segments the market by the setting where products are used, covering hospitals, ambulatory surgical centers, and homecare settings. |
By Product Type
| Sub-Segment | Market Coverage Definition |
|---|---|
| Surgical Gowns & Drapes | Nonwoven apparel and barrier materials used during surgical procedures to protect patients and staff from contamination, the largest product category given the volume of surgical procedures performed. |
| Wound Care Dressings | Nonwoven materials used to cover and manage wounds, including absorbent dressings and composite dressing layers. |
| Face Masks & Respirators | Nonwoven filtration media used in surgical masks and respirators to protect wearers and patients from airborne contamination. |
| Sterilization Wraps | Nonwoven materials used to wrap surgical instruments and supplies to maintain sterility between sterilization and point of use. |
| Others | Additional nonwoven medical products, including bed linens, patient drapes outside the surgical setting, and other disposable barrier materials. |
By Material
| Sub-Segment | Market Coverage Definition |
|---|---|
| Polypropylene-Based | Nonwoven fabrics made primarily from polypropylene fiber, the largest material category given its combination of barrier performance, cost, and ease of manufacturing at scale. |
| Polyester-Based | Nonwoven fabrics made primarily from polyester fiber, often used where additional strength or specific absorbency characteristics are required. |
| Rayon & Others | Nonwoven fabrics made from rayon and other fibers, including blended materials used for specific absorbency or softness requirements. |
By Application
| Sub-Segment | Market Coverage Definition |
|---|---|
| Surgical & Infection Control | Nonwoven products used to maintain a sterile field and prevent infection transmission during surgical and clinical procedures, the largest application given the volume of surgical and infection control product use across healthcare settings. |
| Wound Care | Nonwoven products used in wound dressing and management across acute and chronic wound care settings. |
| Incontinence Products | Nonwoven materials used in absorbent incontinence products for clinical and homecare use. |
| Others | Additional applications, including general hygiene and patient comfort products used in clinical settings. |
By End User
| Sub-Segment | Market Coverage Definition |
|---|---|
| Hospitals | The largest end-user group, reflecting the volume of surgical procedures and infection control protocols in place at hospital facilities. |
| Ambulatory Surgical Centers | Outpatient surgical facilities that consume nonwoven surgical and infection control products at a smaller scale than hospitals but with similar per-procedure requirements. |
| Homecare Settings | Wound care and incontinence product use in patients' homes, supporting care outside the clinical setting. |
Market Assessment Framework
The four-step framework used to size and validate the Medical Nonwoven Products market.
- 1
Bottom-Up Approach
Market size is built from procedure volumes and bed capacity at hospitals, ambulatory surgical centers, and homecare settings, combined with average per-procedure or per-patient consumption of surgical gowns and drapes, wound care dressings, face masks and respirators, and sterilization wraps, then aggregated across materials and regions to arrive at total market value.
- 2
Volume-Based Assessment
Product volume is estimated from disclosed shipment data at major nonwoven fabric converters and medical product manufacturers, cross-checked against hospital procurement volumes for surgical and infection control products.
- 3
Price & Revenue Benchmarking
Average selling prices are benchmarked across product types and materials, including polypropylene-based, polyester-based, and rayon-based nonwovens, using distributor pricing, disclosed contract values, and reported segment revenue from major nonwoven fabric and finished product manufacturers.
- 4
Market Validation & Triangulation
Preliminary estimates are validated through structured interviews with hospital procurement leads, infection control specialists, and nonwoven fabric and finished product manufacturer executives, and cross-checked against company financial disclosures, trade data, and secondary research to reconcile top-down and bottom-up estimates within an acceptable variance.
Specialized Analyst Insights
The February and March 2025 US tariff increases on Chinese nonwoven fabric imports, which raised duties from a prior baseline to 20% within a single month, illustrate how quickly trade policy can affect input costs for buyers of nonwoven medical products. Because China remains the largest single source of nonwoven fabric imports into the US by volume, manufacturers and distributors reliant on Chinese fabric supply face a choice between absorbing higher costs, passing them to customers, or shifting sourcing toward Taiwan, Thailand, or other lower-tariff origins, each of which carries its own price or logistics trade-off.
Nonwovenn's trajectory over the following year, from a direct investment in its own MediTech manufacturing suite to a majority stake acquisition by CorpAcq, a firm that explicitly plans to use the company as a platform for further technical textiles acquisitions, shows how a mid-sized medical nonwovens manufacturer can become both an investor in its own growth and a consolidation target within the same year. CorpAcq's stated intent to make further acquisitions through Nonwovenn suggests this particular change in ownership is a starting point for additional consolidation rather than an end state.
Platinum Equity's agreement to acquire Owens & Minor's Products & Healthcare Services segment, a vertically integrated distributor of medical and surgical supplies to US hospitals, reflects continued private equity interest in the distribution layer of the medical products supply chain, separate from the manufacturing consolidation happening among nonwoven fabric producers. Owens & Minor retaining a 5% equity stake in the divested business suggests some ongoing alignment of interest between the seller and the buyer through the transition.
Freudenberg's acquisition of Foshan United Medical, a Chinese advanced wound care manufacturer with integrated capabilities spanning fiber production, nonwoven manufacturing, and sterilization, gives Freudenberg manufacturing capacity and product lines in a geography and product category, silver-containing antimicrobial and alginate-based dressings, that extend its existing wound care portfolio rather than duplicate it. Acquiring a vertically integrated supplier rather than a single product line lets the buyer gain production control across the full nonwoven wound care manufacturing process at once.
Regional Regulations
Regulatory authorities and requirements across 9 jurisdictions
| Region | Key Regulatory Authorities / Frameworks | Government Regulations and Regulatory Considerations |
|---|---|---|
| North AmericaU.S. | U.S. FDA | Nonwoven surgical gowns, drapes, and face masks are regulated as medical devices requiring FDA 510(k) clearance or exemption depending on classification, with barrier performance evaluated against recognized consensus standards such as AAMI/ANSI PB70. |
| Europe | European Medicines Agency, Notified Bodies | Nonwoven medical products marketed in Europe require Medical Device Regulation certification, with surgical gowns, drapes, and masks evaluated against European standards for protective apparel and medical face mask performance. |
| Asia PacificJapan | MHLW, PMDA | Nonwoven medical products in Japan are regulated under the Pharmaceuticals and Medical Devices Act, with domestic manufacturing standards applied to surgical and infection control products. |
| Asia PacificChina | NMPA | China's NMPA regulates nonwoven medical products as medical devices, with the country also serving as a major global manufacturing base for nonwoven fabric exports subject to destination-market tariffs and trade policy. |
| Asia PacificIndia | CDSCO | Nonwoven medical products in India fall under the Medical Device Rules administered by the CDSCO, with growing domestic manufacturing capacity supporting both local demand and export. |
| Asia PacificSouth Korea | MFDS | South Korea's Ministry of Food and Drug Safety regulates nonwoven medical products as medical devices, with domestic standards applied to surgical and protective apparel. |
| Latin AmericaBrazil | ANVISA | Nonwoven medical products in Brazil are regulated as medical devices by ANVISA, with a mix of domestic production and imported products serving the market. |
| Middle East | National health product regulatory authorities, GCC frameworks | Nonwoven medical product regulation continues to develop across the region alongside growing hospital infrastructure investment and local manufacturing initiatives. |
| Global / International | ISO, ASTM | ISO and ASTM standards for nonwoven fabric barrier performance, filtration efficiency, and biocompatibility shape manufacturing and testing expectations for nonwoven medical products marketed internationally. |
Strategic Activities
5 strategic developments shaping the Medical Nonwoven Products Market
| Date | Company / Companies | Development Type | Development and Impact on Market |
|---|---|---|---|
| Mar 2025 | N/A (U.S. trade policy) | Trade Policy | The United States raised tariffs on Chinese nonwoven fabric imports in two steps, to 10% on February 4, 2025 and to 20% on March 4, 2025. China remained the largest single source of US nonwoven fabric imports by volume, but the tariff increases were expected to raise its relative costs and improve the price position of competing exporters such as Taiwan, Thailand, and Turkiye. [source] |
| Jun 2025 | Nonwovenn | Capacity Investment | Nonwovenn invested in a new medical manufacturing suite, including a Class 8 cleanroom, at its Bridgwater, UK headquarters to support its MediTech division. The investment, partly funded by a key customer, was part of a three-year plan targeting 14% year-on-year growth in the division, which makes products including X-ray detectable surgical materials and reinforced wound care dressings. [source] |
| Oct 2025 | Platinum Equity, Owens & Minor | Acquisition | Platinum Equity signed a definitive agreement to acquire the Products & Healthcare Services segment of Owens & Minor, a vertically integrated distributor of medical and surgical products, including nonwoven surgical and infection control supplies, to hospitals and health systems. Owens & Minor will retain a 5% equity stake in the divested business. [source] |
| Jan 2026 | CorpAcq, Nonwovenn | Acquisition | CorpAcq acquired a majority stake in Nonwovenn, a UK nonwoven fabric manufacturer serving medical, hygiene, and industrial applications with a focus on wound care and protective clothing. CorpAcq, which specializes in acquiring small and medium-sized enterprises, said it plans to use Nonwovenn as a platform for further technical textiles acquisitions. [source] |
| Sep 2026 | Freudenberg Performance Materials, Foshan United Medical | Acquisition | Freudenberg Performance Materials acquired Foshan United Medical, a China-based advanced wound care manufacturer with integrated capabilities spanning fiber manufacturing, nonwoven production, sterilization, and marketing authorization. The acquired company's product portfolio includes polyurethane foam dressings, silicone-coated dressings, and silver-containing antimicrobial dressings. [source] |
Related Analysis
Blog · Healthcare Products, Supplies & SupportTariffs Are Changing Nonwoven Sourcing While Acquisitions Are Changing Who Makes the Products
A tariff increase on Chinese fabric imports and three acquisitions across the supply chain, from a UK fabric maker to a US distributor to a Chinese wound care manufacturer, show medical nonwoven supply reshaping on two fronts at once.
Read the article →Table of Contents: Medical Nonwoven Products Market Report
13 chapters · 92 tables & 66 figures. Expand a chapter to see its sub-sections.
Introduction
- Report Description and Scope
- Market Definition
- Research Methodology
Executive Summary
- Global Market Snapshot, 2025 and 2035
- Key Findings by Segment and Region
- Analyst Viewpoint
Market Dynamics
- Drivers
- Restraints
- Opportunities
- Challenges
- Impact of AI and Automation on Nonwoven Production
Market Analysis Tools
- Porter's Five Forces Analysis
- PESTLE Analysis
- Value Chain and Supply Chain Analysis
Medical Nonwoven Products Market: Segmentation, By Product Type
- Overview and Share Analysis, By Product Type
- Surgical Gowns & Drapes
- Wound Care Dressings
- Face Masks & Respirators
- Sterilization Wraps
- Drapes for ophthalmic and dental use and filtration media
Medical Nonwoven Products Market: Segmentation, By Material
- Overview and Share Analysis, By Material
- Polypropylene-Based
- Polyester-Based
- Rayon, Rayon/viscose and bicomponent materials
Medical Nonwoven Products Market: Segmentation, By Application
- Overview and Share Analysis, By Application
- Surgical & Infection Control
- Wound Care
- Incontinence Products
- Hygiene and personal care
Medical Nonwoven Products Market: Segmentation, By End User
- Overview and Share Analysis, By End User
- Hospitals
- Ambulatory Surgical Centers
- Homecare Settings
Medical Nonwoven Products Market: Production & Volume Analysis
- Units Produced by Product Type, 2025
- Volume-Value Split and Average Selling Price
Medical Nonwoven Products Market: Regional Analysis
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East
- Africa
Medical Nonwoven Products Market: Competitive Landscape
- Market Share Analysis, 2025
- Competitive Positioning Matrix
- Strategic Developments: M&A, Capacity and Partnerships
Company Profiles
- Freudenberg Performance Materials
- Magnera
- Ahlstrom
- Suominen
- Nonwovenn
- Mölnlycke Health Care
- Paul Hartmann AG
- Lohmann & Rauscher
- Solventum
- Winner Medical
- Ansell
- Halyard
- Medline Industries
- Cardinal Health
Appendix
- Abbreviations
- Sources and References
List of Tables (selected)
- Medical Nonwoven Products Market Size, 2023–2035 (USD Million)
- Medical Nonwoven Products Market Size, By Product Type, 2023–2025 (USD Million)
- Medical Nonwoven Products Market Size, By Material, 2023–2025 (USD Million)
- Medical Nonwoven Products Market Size, By Application, 2023–2025 (USD Million)
- Medical Nonwoven Products Market Size, By End User, 2023–2025 (USD Million)
- Medical Nonwoven Products Market Share, By Product Type, 2025 (%)
- Medical Nonwoven Products Market Share, By Material, 2025 (%)
- Medical Nonwoven Products Market Share, By Application, 2025 (%)
- Medical Nonwoven Products Market Share, By End User, 2025 (%)
- Medical Nonwoven Products Production & Volume, By Product Type, 2025 (million pieces produced)
- Medical Nonwoven Products Market Share, By Region, 2025 (%)
- North America Medical Nonwoven Products Market, By Country, 2023–2035 (USD Million)
- Europe Medical Nonwoven Products Market, By Country, 2023–2035 (USD Million)
- Asia Pacific Medical Nonwoven Products Market, By Country, 2023–2035 (USD Million)
- Latin America Medical Nonwoven Products Market, By Country, 2023–2035 (USD Million)
- The Middle East Medical Nonwoven Products Market, By Country, 2023–2035 (USD Million)
- Africa Medical Nonwoven Products Market, By Country, 2023–2035 (USD Million)
- Key Companies: Primary Focus, Strategy and Recent Actions
- Recent Developments in the Medical Nonwoven Products Market, 2025–2026
List of Figures (selected)
- Medical Nonwoven Products Market Size, 2025–2035 (USD Million)
- Medical Nonwoven Products Market: Drivers, Restraints, Opportunities & Challenges
- Medical Nonwoven Products Market Share by Region, 2025
- Medical Nonwoven Products Market — Segmentation Overview
- Medical Nonwoven Products Market Share, By Product Type, 2025 (%)
- Medical Nonwoven Products Market Share, By End User, 2025 (%)
- Medical Nonwoven Products Market — Product Type Mix by Region
- Medical Nonwoven Products Market — Competitive Landscape
- Medical Nonwoven Products Market — At a Glance
- United States Medical Nonwoven Products Market Size, 2023–2035
- Germany Medical Nonwoven Products Market Size, 2023–2035
- South Korea Medical Nonwoven Products Market Size, 2023–2035
You May Also Be Interested In
Medical Disposables Market
Same hospital procurement buyers and single-use product category.
PublishedSterilization Supplies & Consumables Market
Sterilization wraps link both markets through instrument reprocessing.
Antimicrobial Medical Textiles Market
Shared fabric suppliers and infection-prevention use cases.
Home Healthcare Market
Homecare settings are a core end user for dressings and incontinence products.
All VMI market research reports available in PDF. Contact sales@vectomatinsights.com
Frequently Asked Questions
What was the Medical Nonwoven Products market size in 2025?
The Global Medical Nonwoven Products market reached USD 1,372.4 Mn in 2025, up from USD 1,143.3 Mn in 2023, and is projected to grow to USD 3,772.3 Mn by 2035 at a 10.64% CAGR. Surgical gowns & drapes contributed USD 439.2 Mn of 2025 revenue, the largest single product type, while polypropylene-based fabrics accounted for USD 736.9 Mn, according to Vectomat Insights.
Which product type grows fastest in the Medical Nonwoven Products market?
Face masks & respirators are the fastest-growing product type, expanding at a 14.99% CAGR from USD 274.5 Mn in 2025 to USD 1,109.4 Mn by 2035, when they become the largest category. Stockpile replenishment, domestic N95 programmes such as HHS/ASPR's Industrial Base Expansion and routine masking in outpatient care support volumes. Sterilization wraps follow at 12.6%, according to Vectomat Insights.
Why are ambulatory surgical centers important for medical nonwovens?
Ambulatory surgical centers are the fastest-growing end user, compounding at 15.03% from USD 305.7 Mn in 2025 to USD 1,240.0 Mn by 2035. CMS's CY2026 payment rule expanded the procedures ASCs can perform, and these centers buy gowns, drapes and wraps in standardised custom procedure packs, which raises the value captured per case compared with hospital tray assembly, according to Vectomat Insights.
How do tariffs affect the Medical Nonwoven Products market?
US tariffs on Chinese nonwoven fabric rose to 10% in February 2025 and 20% in March 2025, and Section 301 actions raised duties on Chinese masks and respirators through 2026. Buyers are adding second sources in Vietnam, Thailand and the US, and suppliers such as Winner Medical are building tariff-advantaged capacity. Contract pricing has become harder to fix for multi-year terms, according to Vectomat Insights.
Which material dominates medical nonwoven products?
Polypropylene-based materials dominate with 53.7% of 2025 value, or USD 736.9 Mn, because spunbond and SMS polypropylene offers fluid barrier, low cost and sterilization compatibility for gowns, drapes, masks and wraps. Rayon, rayon/viscose and bicomponent materials grow fastest at a 15.1% CAGR on demand for absorbent wound dressings, while polyester-based materials trail at 5.39% and lose share through 2035, according to Vectomat Insights.
What is the outlook for Asia Pacific in the Medical Nonwoven Products market?
Asia Pacific held 30.0% of 2025 revenue, worth USD 411.7 Mn, and is the fastest-growing region. South Korea compounds at 12.8% to USD 274.5 Mn by 2035, Japan is worth USD 119.4 Mn in 2025, and new plants such as Mölnlycke's Changshu wound care site and Winner Medical's Vietnam base expand regional output. The region is on track to rival North America, according to Vectomat Insights.
How did Vectomat Insights research the Medical Nonwoven Products market?
Vectomat Insights combined a bottom-up model, built from procedure volumes, per-procedure consumption and per-piece prices, with a top-down model based on reported revenues of leading producers and distributors. Primary interviews with hospital procurement teams, converters and distributors were cross-checked against company filings, ECDC, WHO, CMS and USTR data, and segment and regional values were reconciled to the base-year total, according to Vectomat Insights.
Access the Complete Medical Nonwoven Products Market Report
300+ pages | 92 tables & 66 figures | 2026–2035 | All 6 regions | PDF
Contact: sales@vectomatinsights.com
About Vectomat Insights
Vectomat Insights is an independent market research firm. Our analysts build every market model in-house, from company revenues, government and regulatory data, and interviews with industry participants, and each report is reviewed by a senior analyst and fact-checked before publication.
Contact: Vectomat Insights | Email: sales@vectomatinsights.com | Website: www.vectomatinsights.com
Request a free sample
Ready to go deeper? Request a free sample of the VMI Medical Nonwoven Products Report — preview key data tables, segmentation depth, and regional forecasts before purchasing.
About this report
Get a free sample of this report
Medical Nonwoven Products Market